Osteoarthritis causes pain, stiffness, and reduced mobility, directly affecting quality of life. Follow-up results after a single injection of Alsavin 2% show clear improvement according to the WOMAC scale across three key indicators: pain, stiffness, and physical function.

• Over the 3-month evaluation period, pain reduction progressively increased from week 2 and remained stable through week 24.
• The improvement rate reached 59%, with 70% of patients rating the outcome as “good” or “very good.”
• Joint stiffness decreased by 45%, supporting better mobility in daily activities.
• Notably, the physical function score improved significantly, increasing by 75%, reflecting enhanced ability to walk and perform physical tasks.

*WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a widely used clinical scale for evaluating pain, joint stiffness, and physical function in patients with osteoarthritis. It is an international standard index that helps objectively and accurately measure treatment effectiveness.

You can find more details on our Facebook page!